Tylenol Maker Sees Stock Plummet After Trump Autism Claims
Summary
The stock price of Kenvue Inc., the maker of Tylenol, fell by 7.5% after former President Donald Trump claimed a link between the painkiller and autism in children during a news conference. Kenvue disagrees with this claim, and health experts have voiced concerns over the announcement, citing insufficient evidence. The administration plans to advise against the use of Tylenol by pregnant women.Key Facts
- Kenvue Inc. is the company that makes Tylenol, a widely used pain and fever medicine.
- Kenvue's share price dropped by 7.5% following comments from Trump about Tylenol and autism.
- Trump linked acetaminophen use in pregnant women to a rise in autism cases.
- Medical experts argue that there is not enough evidence to support this claim.
- The Trump administration plans to advise doctors against prescribing Tylenol to pregnant women.
- The FDA will issue a notice about potential risks and may change the safety label.
- Some studies suggest a link, but more studies are needed to confirm it, say researchers.
- However, other studies, including a notable one in 2024, found no significant link between acetaminophen use during pregnancy and autism.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.